Provided by Tiger Fintech (Singapore) Pte. Ltd.

Benitec Biopharma

11.26
+0.08000.72%
Volume:62.55K
Turnover:703.73K
Market Cap:295.58M
PE:-7.68
High:11.55
Open:11.48
Low:11.04
Close:11.18
Loading ...

Benitec Biopharma Advances BB-301 Clinical Study

TIPRANKS
·
10 Jul

Benitec Biopharma Inc - Announces Final Subject of Cohort 1 Treated With Bb-301 - SEC Filing

THOMSON REUTERS
·
10 Jul

Benitec reports DSMB recommendation to continue enrollment of Phase 1b/2a study

TIPRANKS
·
09 Jul

Benitec Biopharma Provides Operational Updates

THOMSON REUTERS
·
09 Jul

Benitec Biopharma Provides Operational Updates

GlobeNewswire
·
09 Jul

Benitec Biopharma Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
07 Jul

TD Cowen Initiates Benitec Biopharma at Buy

MT Newswires Live
·
07 Jul

Benitec Biopharma initiated with a Buy at TD Cowen

TIPRANKS
·
07 Jul

Innovative Gene Therapy Approach Drives Buy Rating for Benitec Biopharma

TIPRANKS
·
07 Jul

Benitec Biopharma files to sell 900K shares of common stock for holders

TIPRANKS
·
24 May

Benitec Biopharma Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Dow Jones
·
19 May

Benitec Biopharma Price Target Maintained With a $20.00/Share by JMP Securities

Dow Jones
·
15 May

Benitec Biopharma Q3 EPS $(0.24) Beats $(0.35) Estimate

Benzinga
·
14 May

Benitec Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Benitec Biopharma Reports Q3 2025 Net Loss of $9.4M, EPS at $0.24, No Revenue Recorded

Reuters
·
14 May

BRIEF-Benitec Biopharma Q3 Operating Income USD -10.2 Million

Reuters
·
14 May

Benitec Biopharma reports Q3 EPS (24c) vs. (23c) last year

TIPRANKS
·
14 May

Benitec Biopharma Releases Third Quarter 2025 Financial Results

THOMSON REUTERS
·
14 May

Benitec Biopharma Q3 Net Income USD -9.4 Million

THOMSON REUTERS
·
14 May

Press Release: Benitec Biopharma Releases Third Quarter 2025 Financial Results

Dow Jones
·
14 May